arrow
返回
J

José Antonio Sacristán

Eli Lilly

26H指数
117论文数
3.2K被引数
收录论文 31
发表时间
The Impact of Patient Support Programs in Europe: A Systematic Literature Review
err2022-06-21
err6
errOAAI
errAntonio Sacristan, Jose; Artime, Esther; Diaz-Cerezo, Silvia; Comellas, Marta; Perez-Carbonell, Lucia; Lizan, Luis
err分享
err收藏
Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (EUROPA study)
err2020-04-16
err0
errOAAI
errGomez, JC; Sacristan, JA; Carrasco, PR; Alvarez, E; Bobes, J; Cañas, F; Gascon, J; Gibert, J; Gutierrez, M
err分享
err收藏
Antipsychotic treatment, adverse events and health-related quality of life
err2020-04-16
err0
errOAAI
errBadia, X; Casado, A; Sacristán, JA; Gómez, JC; Gregor, KJ; Gavart, S
err分享
err收藏
What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis
err2020-02-22
err14
errOAAI
errDiaz-Torne, Cesar; Urruticoechea-Arana, Ana; Ivorra-Cortes, Jose; Diaz, Silvia; Dilla, Tatiana; Antonio Sacristan, Jose; Inciarte-Mundo, Jose; Comellas, Marta; Prades, Miriam; Lizan, Luis
err分享
err收藏
Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?
err2020-01-01
err11
errOAAI
errOliva-Moreno, Juan; Puig-Junoy, Jaume; Trapero-Bertran, Marta; Epstein, David; Pinyol, Carme; Antonio Sacristan, Jose
err分享
err收藏
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making
err2019-08-14
err28
errOAAI
errPablos, Jose Luis; Jover, Juan Angel; Roman-Ivorra, Jose Andres; Inciarte-Mundo, Jose; Dilla, Tatiana; Sacristan, Jose Antonio; Comellas, Marta; Lizan, Luis
err分享
err收藏
err分享
err收藏
err分享
err收藏
Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology
err2016-10-07
err9
errOAAI
errSacristan, Jose A.; Lizan, Luis; Comellas, Marta; Garrido, Pilar; Avendano, Cristina; Cruz-Hernandez, Juan J.; Espinosa, Javier; Dilla, Tatiana
err分享
err收藏
DO NEW CANCER DRUGS OFFER GOOD VALUE FOR MONEY? THE PERSPECTIVE OF ONCOLOGISTS, PAYERS, PATIENTS, AND GENERAL POPULATION
err2015-08-01
err0
errOAAI
errDilla, Tatiana; Lizan, Luis; Paz, Silvia; Garrido, Pilar; Avendano-Sola, Cristina; Cruz, Juan J.; Espinosa, Javier; Sacristan, Jose A.
err分享
err收藏
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparison
err2014-12-02
err9
errOAAI
errDilla, Tatiana; Moeller, Joergen; O'Donohoe, Paul; Alvarez, Maria; Sacristan, Jose A.; Happich, Michael; Tockhorn, Antje
err分享
err收藏
DO NEW CANCER DRUGS OFFER GOOD VALUE FOR MONEY? THE PERSPECTIVE OF ONCOLOGISTS, PAYERS, PATIENTS, AND GENERAL POPULATION
err2014-11-01
err0
errOAAI
errDilla, T.; Lizan, L.; Paz, S.; Garrido, P.; Avendano, C.; Cruz, J. J.; Espinosa, J.; Sacristan, J. A.
err分享
err收藏
COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
err2011-11-01
err2
PREAI
errDilla, T.; O'Donohoe, P.; Moeller, J.; Alvarez, M.; Sacristan, J.; San, L.; Happich, M.; Tockhorn, A.
err分享
err收藏